ACADIA Pharmaceuticals Inc (ACAD) — Free Cash Flow Generation Index
ACADIA Pharmaceuticals Inc (ACAD) has a Free Cash Flow Generation Index of 0.85x as of March 2026. Free cash flow of $28.77 Million represents 1% of operating cash flow ($33.98 Million). Read ACADIA Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for ACADIA Pharmaceuticals Inc across 3 annual periods. Explore ACAD capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for ACADIA Pharmaceuticals Inc. For the full company profile including market capitalisation, see ACADIA Pharmaceuticals Inc (ACAD) total market value.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $105.15 Million | $109.84 Million | $4.69 Million | ▼ -4.0% |
| 2024 | 1.00x | $157.20 Million | $157.72 Million | $523.00K | ▲ +171.3% |
| 2023 | -1.40x | $-23.35 Million | $16.70 Million | $40.05 Million | — |